Nanostructured Lipid Carriers Enable In Vivo Efficacy of Parthenolide in Schistosoma mansoni Infection
Pharmaceutics · 03.06.2026 · 18 (6) · 694
DOI: 10.3390/pharmaceutics18060694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 03.06.2026. Verfasst von José Márcio Fernandes da Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Juiz de Fora, R. José Lourenço Kelmer s/n, Campus Universitári…. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, São Paulo Research Foundation, Coordination for the Improvement of Higher Education Personnel.
Abstract (Originalsprache)
Background
Schistosomiasis remains a major neglected tropical disease, with praziquantel (PZQ) as the only widely used treatment, despite its limitations. Parthenolide (PTL), a sesquiterpene lactone, exhibits potent in vitro antischistosomal activity; however, its poor aqueous solubility, low oral bioavailability, and chemical instability may limit its in vivo efficacy.
Objective
This study investigated whether nanoencapsulation in nanostructured lipid carriers (NLC) could enable the in vivo antischistosomal activity of PTL.
Methods
PTL was isolated from Tanacetum parthenium and incorporated into NLC using hot emulsification followed by ultrasonication. The resulting formulation (NLC-PTL) was physicochemically characterized, and its in vivo antischistosomal efficacy was evaluated in a murine model of Schistosoma mansoni infection.
Results
NLC-PTL exhibited nanoscale size, low polydispersity, high encapsulation efficiency, and sustained drug release. In vivo, free PTL showed no significant effect on worm burden, whereas NLC-PTL achieved a marked reduction (77.9%) in adult worms and significantly decreased egg output compared to controls (p < 0.001). Blank NLC had no antiparasitic effect.
Conclusions
Nanoencapsulation was associated with in vivo antischistosomal activity of PTL compared to the free compound. These findings suggest that formulation strategies may influence the in vivo performance of lipophilic natural products in schistosomiasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Juiz de Fora, R. José Lourenço Kelmer s/n, Campus Universitário, Juiz de Fora 36036-900, MG, Brazil.
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos 07023-070, SP, Brazil.
- Núcleo de Pesquisa em Doenças Negligenciadas, Instituto Científico e Tecnológico, Universidade Brasil, São Paulo 08230-030, SP, Brazil.
ORCID-Profile: Josué de Moraes, Guilherme Diniz Tavares, Ademar Alves Da Silva Filho
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- São Paulo Research Foundation
- Coordination for the Improvement of Higher Education Personnel
- National Council for Scientific and Technological Development
Zitieren
APA
Silva, J. M. F. D., Silva, D. M. E., Costa, D. S., Amaro, M. C., Cajas, R. A., de Moraes, J., Tavares, G. D., & Da Silva Filho, A. A. (2026). Nanostructured Lipid Carriers Enable In Vivo Efficacy of Parthenolide in Schistosoma mansoni Infection. Pharmaceutics, 18(6), 694. https://doi.org/10.3390/pharmaceutics18060694
Vancouver
Silva JMFD, Silva DME, Costa DS, Amaro MC, Cajas RA, de Moraes J, et al. Nanostructured Lipid Carriers Enable In Vivo Efficacy of Parthenolide in Schistosoma mansoni Infection. Pharmaceutics. 2026;18(6):694. doi:10.3390/pharmaceutics18060694
BibTeX
@article{Silva2026,
author = {Silva, José Márcio Fernandes da and Silva, Dominique Mesquita E and Costa, Danilo de Souza and Amaro, Monique C and Cajas, Rayssa A and de Moraes, Josué and Tavares, Guilherme Diniz and Da Silva Filho, Ademar Alves},
title = {Nanostructured Lipid Carriers Enable In Vivo Efficacy of Parthenolide in Schistosoma mansoni Infection},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {6},
pages = {694},
doi = {10.3390/pharmaceutics18060694}
}
EUVIMED